Related by context. Frequent words. (Click for all words.) 53 dissident slate 50 Holds Annual Meeting 48 CFO Exercises Options 48 Directors Declares Quarterly 47 Stockholders Vote 47 Director Exercises Options 46 Declares Common 46 Directors Elects 46 A. Pontius 46 Stockholders Approve Merger 46 Mitarotonda 46 Shareholders Elect 46 Extends Tender Offer 46 Files Shelf Registration Statement 45 Klein Esq 45 Risk Metrics 45 directors 45 Annual Stockholders 44 CFO resigns 44 Annual Meeting Date 44 Declares Quarterly Dividends 44 Principal Executive Officer 44 Deutsch USA TODAY 44 Nominating Committee 44 Alnara 43 CFS Bancorp 43 Shareholder Vote 43 PROXY Governance 43 Dynogen 43 Directors 43 Declares Regular Dividend 43 PTV Sciences 43 Ajdler 43 materially undervalues 43 filed Solicitation Recommendation 43 Karpus 43 Declares Third Quarter 43 Lilly 42 Announces Organizational Changes 42 CtW 42 Roy Bostock 42 Shareholders Approve Merger 42 Nominating 42 Adventrx 42 offer substantially undervalues 42 L. Clendenin 42 Sunesis Pharmaceuticals 42 Robotti 42 stockholders 42 PROXY Governance Inc. 42 Obrem 42 COO Quick Facts 41 Laddcap 41 ValueAct 41 nominees 41 Files Annual Report 41 Announces Departure 41 proposal significantly undervalues 41 Kent Kresa 41 maximizing stockholder 41 Declares Regular Quarterly Dividend 41 Wynnefield Group 41 Q3 Loss Narrows 41 chairman Roy Bostock 41 Preliminary Proxy Statement 41 Raises Bid 41 Ramius 41 Shamrock Activist Value 41 H. Birnbaum 40 Desmond Hellmann 40 solicit proxies 40 NYSE BVF TSX 40 Ramius LLC 40 Declares Cash Dividend 40 Special Shareholder Meeting 40 E. Levi Esq 40 Penwest Pharmaceuticals 40 Stockholders Approve 40 Engelhard stockholders 40 Cent Dividend 40 proposal substantially undervalues 40 Increases Quarterly Cash Dividend 40 Adopts Shareholder Rights 40 QuatRx 40 Ziopharm 40 Incentive Compensation Plan 40 Riskmetrics 40 Crescendo Partners 40 Chair Elect 40 Syntonix 40 By Darren Sabedra 40 maximize stockholder 40 By Becky Yerak 40 Merger Proposal 40 BLUE proxy card 39 Declares Regular Quarterly 39 Greisch 39 Strategic Alternatives 39 Emmens 39 AnorMed 39 SUAI